DISCUSSION
Facelift surgery, known as rhytidectomy, is a common cosmetic surgery used to provide a more youthful facial appearance. Various complications of rhytidectomy include hematoma, nerve injuries, skin necrosis, hair loss, infection, and parotid gland duct injury. Incidence of parotid gland duct injury has been increasing as surgical methods for rhytidectomy have been becoming more aggressive. Parotid duct injury may result in a parotid fistula, which is a localized, subcutaneous cavity containing saliva. Disruption of the parotid duct or parenchyma after trauma such as a surgical procedure or facial trauma is one of the major causes of parotid fistula. Extravasation of saliva into glandular and periglandular tissue occurs, leading to significant swelling, infection in the cheek, and abnormal salivary secretion.
Parotid fistula has the potential to resolve spontaneously within 1 month because scar tissue formation occurs around the parotid parenchyma, which prevents further flow of saliva [
6]. However, secretion of a large amount of saliva may inhibit healing due to the constant flow of saliva. During the process of delayed wound healing of a parotid fistula, scar contracture may develop, resulting in cosmetic problems. Nevertheless, there are no definite treatment options for parotid fistula. Both surgical and non-surgical approaches have been used to treat parotid fistula.
Conservative approaches include repetition of aspiration, application of a pressure dressing, taking scopolamine, and radiation therapy. However, radiation therapy increases cancer risk, while repetitive aspiration may cause further infections. Continued usage of anticholinergic medication can cause memory problems, urinary retention, and even paralytic ileus [
7,
8]. Surgical procedures such as tympanic neurectomy and marsupialization can also be used to treat parotid fistula after parotidectomy [
9,
10]. However, patients tend to prefer conservative to surgical approaches due to the invasiveness of the latter for cosmetic reasons. Overall, management of a parotid fistula is still controversial.
Botulinum toxin has been shown to have therapeutic effects in patients with sialorrhea. Injection of botulinum toxin into salivary glands is a safe and clinically useful method to treat patients suffering from parotid fistula. Botulinum toxin blocks saliva production by inhibiting cholinergic autonomic parasympathetic and postganglionic sympathetic acetylcholine release at the terminal end of the salivary gland.
Botulinum toxin is used to treat various diseases such as sialorrhea and hyperhidrosis [
5]. It has also been used to treat drooling associated with Parkinson’s disease, pediatric drooling, parotid fistula after parotidectomy, and severe sialorrhea in amyotrophic lateral sclerosis patients or those with neurodegenerative diseases [
1,
11,
12].
However, no previous study has reported injection of botulinum toxin to treat a parotid fistula following facelift surgery.
Several authors have discussed the clinically effective dose of botulinum injection [
4,
11-
14], but there is no consensus regarding dose or method. Various doses have been used; for example 100 units of botulinum toxin type A diluted in 4 mL of saline, or 2,500 mouse-units of botulinum toxin type B diluted in 4 mL of saline [
11,
12]. The dose of the toxin has been as high as 100 units at a site, or as low as 10 units at a site. There is also a diversity of injection methods. Reid et al. injected 25 U in the parotid gland and 25 U in the submandibular gland. Laskawi et al. suggested using 10-40 units at two to three sites, while Gregory et al. injected 50 units at two separate sites of the parotid gland for a total dose of 100 units [
12-
14]. In our study, we used a total of 50 units of intraglandular botulinum toxin type A (Botulex
®, Hugel, Chuncheon, Korea) diluted in 3 mL of normal saline, and injected 2 unites at interjunction distances of 1 cm.
We described two patients who complained of excessive salivary secretion and swelling around the right parotid gland immediately after facelift surgery. Amylase concentration, starch-iodine test results, and sialography results led us to diagnose a parotid fistula in both patients. Instead of performing invasive surgery, we choose to inject botulinum toxin to treat the parotid fistula in both cases. In addition to botulinum toxin injection, patients were instructed to eat rice porridge and minimize temporomandibular joint motion. This is because chewing movements increase salivation from the parotid gland; if mastication is not controlled, then the symptoms of salivary secretion will be exacerbated. Facial bandage and scopolamine were also prescribed. Salivary secretion and swelling subsided effectively and both patients were satisfied with the cosmetic results.
In conclusion, injection of botulinum toxin type A, application of a facial bandage for compression, taking scopolamine, and limiting temporomandibular joint motion is an effective treatment approach for parotid fistulas in facial surgery patients that should be considered before performing an invasive surgical procedure.